Medical Imaging Solutions

Medical Imaging Solutions, headquartered in Shanghai, is a global innovator in advanced medical imaging technologies and intelligent healthcare solutions.

Reviewed by 7wData

On this page

Profile

Develops advanced medical imaging technologies and intelligent healthcare solutions.

Medical Imaging Solutions, headquartered in Shanghai, is a global innovator in advanced medical imaging technologies and intelligent healthcare solutions. Founded in 2011, the company has grown to become a significant player in the medical imaging sector, with a focus on developing cutting-edge technologies that enhance clinical outcomes. As of 2025, Medical Imaging Solutions reported a revenue of RMB 13.80 billion, marking a 33.98% year-on-year increase, and a net profit of RMB 1.87 billion, up 48.14% from the previous year.

The company’s R&D investment reached RMB 2.62 billion in 2025, reflecting its commitment to innovation. Medical Imaging Solutions has launched over 150 products, including 75 with EU CE certification and 58 cleared by the U.S. FDA via the 510(k) pathway.

The company’s overseas revenue surged to RMB 3.43 billion in 2025, driven by its expansion into over 100 countries and regions. Key products include the uSONIQUE ultrasound series, which completed the company’s imaging portfolio. Despite its growth, the company faces challenges such as intense competition and regulatory hurdles in new markets.

Track Medical Imaging Solutions and 240+ vendors.

48k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Hospitals and healthcare providers
  • Clinical and research institutions
  • Medical imaging centers
  • Healthcare systems in emerging markets
  • Academic institutions

Strengths and what to watch

Strengths

  • Strong R&D investment with RMB 2.62 billion in 2025
  • Global presence in over 100 countries and regions
  • Comprehensive product portfolio including FDA-cleared devices

Watch for

  • Intense competition in the medical imaging sector
  • Regulatory challenges in new markets
  • Dependence on overseas revenue growth

Key Information

Founded
2011
Headquarters
Shanghai

Frequently Asked Questions

What does Medical Imaging Solutions specialize in?

Medical Imaging Solutions develops advanced medical imaging technologies and intelligent healthcare solutions. Headquartered in Shanghai, it focuses on enhancing clinical outcomes through innovation, with over 150 products including 75 CE-certified and 58 FDA-cleared devices. The company operates globally across 100+ countries.

How has Medical Imaging Solutions performed financially?

In 2025, Medical Imaging Solutions reported RMB 13.80 billion revenue, a 33.98% annual increase, and RMB 1.87 billion net profit, up 48.14%. Overseas revenue surged to RMB 3.43 billion, driven by expansion into 100+ countries, supported by RMB 2.62 billion R&D investment.

What are Medical Imaging Solutions' key products?

The company's portfolio includes the uSONIQUE ultrasound series and 150+ imaging products. Seventy-five devices have EU CE certification, while 58 are cleared by the U.S. FDA via the 510(k) pathway, demonstrating compliance with international medical standards.

Where does Medical Imaging Solutions operate?

Medical Imaging Solutions serves hospitals, clinics, and research institutions across 100+ countries, with strong presence in emerging markets. Its global expansion contributed to RMB 3.43 billion overseas revenue in 2025, though regulatory hurdles in new markets remain a challenge.

What certifications do Medical Imaging Solutions products have?

The company holds 75 EU CE certifications and 58 U.S. FDA clearances for its medical imaging devices. These certifications validate compliance with stringent safety and efficacy standards, facilitating global market access and clinical adoption.

What challenges does Medical Imaging Solutions face?

Key challenges include intense sector competition, regulatory hurdles in new markets, and dependence on overseas revenue growth. Despite 33.98% revenue growth in 2025, maintaining innovation and market expansion requires ongoing R&D investment and regulatory compliance.

Sources

  1. www.prnewswire.com — Revenue and net profit figures for 2025 and Q1 2026
  2. www.prnewswire.com — R&D investment and product portfolio details
  3. www.prnewswire.com — Overseas revenue and global expansion statistics
  4. www.prnewswire.com — Launch of the uSONIQUE ultrasound series